Human herpesvirus type 8 infections among solid organ transplant recipients

Pediatric Transplantation

Volumn 6, Issue 3, 2002, Pages 187-192

  Allen, Upton D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Human herpesvirus type 8; Kaposi's sarcoma; Transplantation

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; CIDOFOVIR; FOSCARNET; GANCICLOVIR; VIRUS DNA; ANTIVIRUS AGENT;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BONE MARROW DEPRESSION; CLINICAL FEATURE; DISEASE ASSOCIATION; HERPES; HUMAN; HUMAN HERPESVIRUS 8; INFECTION COMPLICATION; KAPOSI SARCOMA; LABORATORY DIAGNOSIS; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIMARY EFFUSION LYMPHOMA; REVIEW; SUPERINFECTION; TREATMENT PLANNING; VIRUS INFECTION; VIRUS INFECTIVITY; GRAFT REJECTION; HERPES VIRUS INFECTION; PEDIATRICS; VIROLOGY;

ANTIVIRAL AGENTS; GRAFT REJECTION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMAN; ORGAN TRANSPLANTATION; PEDIATRICS; POSTOPERATIVE COMPLICATIONS; HUMANS;

EID: 0036022223     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.02006.x     Document Type: Review

References (56)

1. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
2. Isolation of a new herpesvirus from CD4+ T cells
3. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
4. Bone marrow failure associated with human herpesvirus 8 infection after transplantation
5. Rhadinoviruses (gamma 2-herpes-viruses) of old world primates: Models for KSHV/HHV8-associated disease?
6. KSHV (HHV8) infection
7. The descent of human herpesvirus 8
8. Kaposi's sarcoma-associated herpesvirus
9. Kaposi's sarcoma
10. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells
11. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8
12. Kaposi's sarcoma and herpesvirus-like DNA sequences in sensory ganglia
13. Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma
14. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
15. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
16. Propogation of a human herpesvirus from AIDS-associated Kaposi's sarcoma
17. The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
18. Human herpesvirus 8 infection occurs following adolescence in the United States
19. Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA
20. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents
21. Kaposi's sarcoma in childhood: An analysis of 100 cases from Uganda and relationship to HIV infection
22. Serological and virological evidence of non-sexual transmission of human herpes type 8 (HHV8)
23. Secondary neoplasms as a consequence of transplantation and cancer therapy
24. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia
25. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients
26. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation
27. Risk of Kaposi's sarcome-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sacrcoma patients
28. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients
29. Posttransplant human herpes virus 8 infection and seroconversion in a Kaposi's sarcoma affected kidney recipient transplanted from a human herpes virus 8 positive living related donor
30. Human herpes virus 8 infection in kidney transplant patients in Belgium
31. HHV8 in renal transplant recipients
32. Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients
33. Human herpesvirus type 8 (Kaposi's sarcoma-associated herpesvirus)
34. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Kaposi's sarcoma, malignant lymphoma, and other diseases
35. The clinical behaviour of localized and multicentric Castleman disease
36. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma
37. Evidence against KSHV infection in the pathogenesis of multiple myeloma
38. Identification of human herpesvirus 8-specific cytotoxic T-cell responses
39. Human herpesvirus 6, 7 and 8
40. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
41. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
42. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
43. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunoflourescence antigen
44. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein
45. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen
46. The 222- to 234-kilodalton latent nuclear protein (LAN) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen
47. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection
48. Identifying human herpesvirus 8 infection: Performance characteristics of serologic assays
49. Comparison of serologic assays for detection of antibodies against Human herpesvirus 8
50. Absence of detectable human herpesvirus 8 in the semen of human immunodeficiency virus-infected men without Kaposi's sarcoma
51. Multicenter comparision of PCR assays for detection of human herpesvirus 8 DNA in semen
52. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates
53. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients
54. Human herpesvirus 8 (HHV8). II. Pathogenic role and sensitivity to antiviral drugs
55. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant
56. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection